Bio-better avoids preliminary injunction in Germany
The first preliminary injunction decision in Germany relating to a ‘bio-better’-type drug has been made in Amgen v Teva in the Düsseldorf District Court. The injunction was rejected and an appeal is pending.
The product of Amgen, Lipegfilgastrim, the owner of the patent for which enforcement was sought, was not itself covered by the patent…
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
For the tax year from 6 April 2014, the standard lifetime allowance has reduced from £1.5m to £1.25m.
One of the areas highlighted last year by the Regulator was the regulation of workplace DC pension schemes.
Analysis from The Lawyer
As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014.
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world